BackgroundCheck.run
Search For

Haifeng E Chen, 6547 Saint James Pl, Piedmont, CA 94611

Haifeng Chen Phones & Addresses

Upper Chichester, PA   

Piedmont, CA   

111 Hogan Ridge Ct, Chapel Hill, NC 27516   

Castro Valley, CA   

1201 Harbor Bay Pkwy, Alameda, CA 94502   

Kansas City, KS   

San Mateo, CA   

Media, PA   

Mentions for Haifeng E Chen

Career records & work history

Lawyers & Attorneys

Haifeng Chen Photo 1

Haifeng Chen - Lawyer

ISLN:
1000366634
Admitted:
2017
University:
Emory University School of Law

Haifeng Chen resumes & CV records

Resumes

Haifeng Chen Photo 18

Ceo At Virovek, Inc.

Position:
CEO at Virovek, Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Virovek, Inc. - Hayward, California since Jul 2006
CEO
Asklepois BioPharmaceutical, Inc. 2005 - 2006
Vice President
Avigen 2000 - 2005
Research Scientist IV
Genovo 1997 - 2000
Senior Scientist
Cell Genesys 1996 - 1997
Postdoctoral Fellow
Sun Yat-sen Univeristy 1985 - 1989
Researcher
Education:
Universität des Saarlandes 1989 - 1992
Doctor of Philosophy (Ph.D.), Virology
Sichuan University 1982 - 1985
Master of Science (MS), Plant Genetics
Sun Yat-Sen University 1978 - 1982
Bachelor of Science (BS), Biology
Haifeng Chen Photo 19

Owner At Virovek, Inc.

Position:
Owner at Virovek, Inc.
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Virovek, Inc. since Jul 2006
Owner
Asklepois BioPharmaceutical, Inc. Jun 2005 - Jun 2006
VP
Avigen, Inc. May 2000 - Jun 2005
Research Scientist IV
Genovo 1997 - 2000
Senior Scientist
Cell Genesys 1996 - 1997
Postdoctoral Fellow
Education:
Universität des Saarlandes 1989 - 1992
PH.D, Virology
Sichuan University 1982 - 1985
Master, Plant Genetics
Sun Yat-Sen University 1978 - 1982
BS, Biology
Skills:
Protein Expression, Gene Therapy, Biotechnology, Lifesciences, Molecular Biology, Biochemistry, Technology Transfer, Patents, Licensing, Intellectual Property, Cell Biology, Cell Culture
Languages:
Chinese
English
German
Haifeng Chen Photo 20

Haifeng Chen

Publications & IP owners

Us Patents

Production Of Recombinant Aav Using Adenovirus Comprising Aav Rep/Cap Genes

US Patent:
7115391, Oct 3, 2006
Filed:
Sep 29, 2000
Appl. No.:
10/089394
Inventors:
Haifeng Chen - Castro Valley CA, US
Gary Kurtzman - Bryn Mawr PA, US
Assignee:
Genovo, Inc. - Seattle WA
International Classification:
C12P 21/06
C12N 15/63
C12N 15/64
A61K 39/12
A01N 63/00
US Classification:
435 691, 435455, 435456, 4353201, 435 9141, 435 9142, 424 932, 424 9321, 4241991
Abstract:
This invention relates to novel adenoviruses useful in the production of high titers of recombinant adeno-associated virus (rAAV) comprising a foreign DNA insert and methods of making these adenoviruses. The adenovirus comprises the AAV rep gene in which the p5 promoter is replaced by a minimal promoter or by no promoter. The invention also provides methods of producing high levels of rAAV as a substantially homogenous preparation and composition of rAAV.

Novel Compositions And Methods For Production Of Recombinant Virus

US Patent:
2005001, Jan 27, 2005
Filed:
Aug 17, 2004
Appl. No.:
10/920647
Inventors:
Siyamak Rasty - Wilmington DE, US
Matthew Gonda - Vestavia Hills AL, US
Haifeng Chen - Media PA, US
Assignee:
Genovo, Inc. - Seattle WA
International Classification:
C12N015/86
US Classification:
435456000
Abstract:
This invention relates to novel nonmammalian carrier vectors and viruses useful in the production of high titers of recombinant viruses which may contain foreign DNA inserts or which may be point-mutated or deleted viruses, and methods of producing those viruses. The nonmammalian carrier vector (“carrier vector”) is a chimeric vector which includes those portions of a nonmammalian virus backbone which allow replication in a nonmammalian host cell. The carrier vector includes various nucleic acid cassettes, which may include an embedded recombinant viral genome containing a desired transgene, components necessary for production of a replication-defective recombinant virus containing the transgene, and domains that permit the carrier vector to bind to mammalian cells. The invention also provides methods of producing high concentrations of recombinant virus as a substantially homogeneous. preparation, compositions to produce the recombinant virus, and novel recombinant viruses.

Production Of Recombinant Aav Using Adenovirus Comprising Aav Rep/Cap Genes

US Patent:
2007006, Mar 22, 2007
Filed:
Aug 25, 2006
Appl. No.:
11/509855
Inventors:
Haifeng Chen - Media PA, US
Gary Kurtzman - Bryn Mawr PA, US
International Classification:
A61K 48/00
C12N 15/861
US Classification:
424093200, 435456000, 977802000
Abstract:
This invention relates to novel adenoviruses useful in the production of high titers of recombinant adeno-associated virus (rAAV) comprising a foreign DNA inert and methods of making these adenoviruses. The adenovirus comprises the AAV rep gene in which the p5 promoter of rep is replaced by a minimal promoter or by no promoter. The invention also provides methods of producing high levels of rAAV as a substantially homogeneous preparation and compositions of rAAV.

Enhanced Production Of Infectious Parvovirus Vectors In Insect Cells

US Patent:
2009019, Jul 30, 2009
Filed:
Jan 22, 2007
Appl. No.:
12/161202
Inventors:
Jude Samulski - Chapel Hill NC, US
Haifeng Chen - Castro Valley CA, US
Assignee:
ASKLEPIOS BIOPHARMACEUTICAL, INC. - Chapel Hill NC
International Classification:
C12P 19/34
C12N 5/06
US Classification:
435 914, 435325
Abstract:
A method of producing a packaged parvovirus vector, the method comprising: (a) providing an insect cell; (b) introducing into the insect cell one or more vectors comprising nucleotide sequences encoding: (i) a transgene flanked by TRs; and (ii) baculovirus packaging functions comprising Rep components and Cap components sufficient to result in packaging of infective parvovirus particles, wherein VP1 is supplemented relative to VP2 and VP3 sufficient to increase the production of infectious viral particles; and (c) introducing into the cell a nucleic acid encoding baculovirus helper functions for expression in the insect cell; (d) culturing the cell under conditions sufficient to produce the infectious packaged parvovirus vector.

Expression In Insect Cells Of Genes With Overlapping Open Reading Frames, Methods And Compositions Therefor

US Patent:
2009020, Aug 13, 2009
Filed:
Aug 24, 2007
Appl. No.:
12/297958
Inventors:
Haifeng Chen - Castro Valley CA, US
Assignee:
Virovek, Inc. - Hayward CA
International Classification:
C12P 21/06
C12P 19/34
C12N 7/00
C12N 5/10
C12N 15/63
C07H 21/04
US Classification:
435 691, 435 911, 4352351, 435348, 4353201, 536 235
Abstract:
The present teachings disclose nucleic acid cassettes for expressing in an insect cell a plurality of polypeptides encoded by a gene comprising overlapping open reading frames (ORFs). A cassette comprises, in 5′ to 3′ order, a) a first insect cell-operable promoter, b) a 5′ portion of a gene comprising a first ORF of the gene, c) an intron comprising a second insect cell-operable promoter, and d) a 3′ portion of the gene comprising at least one additional ORF. Vectors and insect cells comprising the cassettes are also disclosed, as well as methods for production of recombinant adeno-associated virus in insect cells using the cassettes.

Methods For Production Of A Recombinant Adeno-Associated Virus

US Patent:
6793926, Sep 21, 2004
Filed:
May 25, 2000
Appl. No.:
09/578561
Inventors:
Siyamak Rasty - Wilmington DE
Matthew A. Gonda - Vestavia Hills AL
Haifeng Chen - Media PA
Assignee:
Genovo, Inc. - Seattle WA
International Classification:
A61K 3912
US Classification:
4241991, 4241841, 4242041, 4242331, 435 691, 4352351, 4353201, 435455, 435456, 435457, 514 44, 536 231, 536 2372
Abstract:
This invention relates to novel nonmammalian carrier vectors and viruses useful in the production of high titers of recombinant viruses which may contain foreign DNA inserts or which may be point-mutated or deleted viruses, and methods of producing those viruses. The nonmammalian carrier vector (âcarrier vectorâ) is a chimeric vector which includes those portions of a nonmammalian virus backbone which allow replication in a nonmammalian host cell. The carrier vector includes various nucleic acid cassettes, which may include an embedded recombinant viral genome containing a desired transgene, components necessary for production of a replication-defective recombinant virus containing the transgene, and domains that permit the carrier vector to bind to mammalian cells. The invention also provides methods of producing high concentrations of recombinant virus as a substantially homogeneous preparation, compositions to produce the recombinant virus, and novel recombinant viruses.

Baculovirus Expression System

US Patent:
2020040, Dec 31, 2020
Filed:
Jun 25, 2020
Appl. No.:
16/912084
Inventors:
- Hayward CA, US
Haifeng Chen - Hayward CA, US
International Classification:
C12N 7/00
C12N 15/86
A01K 67/033
Abstract:
The present disclosure relates to a heterologous recombinant baculovirus (rBV) expression system for the production of foreign heterologous proteins in insect cells. This system comprises a recombinant baculovirus backbone within a genome with a deletion in the cathepsin gene into which foreign gene cassettes can be integrated, and an insect cell that can be infected by the Δv-cath-rBV, and in which the foreign proteins and/or viral vectors or particles are expressed.

Three Phase Partitioning (Tpp) Method For Virus Purification

US Patent:
2019016, May 30, 2019
Filed:
Nov 28, 2018
Appl. No.:
16/203055
Inventors:
- Hayward CA, US
Haifeng Chen - Piedmont CA, US
International Classification:
C12N 1/02
C12N 1/04
C12N 1/06
C12N 5/07
Abstract:
Methods of purifying a virus from a virus-infected cell lysate using three-phase partitioning (TPP) are disclosed. The methods comprise a first round of TPP, including mixing a cell lysate comprising a virus with ammonium sulfate and t-butanol, and separating the mixture, thereby forming a first aqueous phase, a first organic phase, and a first interphase. The first aqueous phase can comprise the virus, which can be subjected to a second round of TPP, resulting in a second aqueous phase, a second organic phase, and a second interphase. The second interphase can comprise highly purified virus. The methods can comprise subjecting a first aqueous phase to further purification by column chromatography or density gradient centrifugation. Purification of AAV, including AAV2, AAV5 and AAV6, from lysates of infected insect cell cultures is demonstrated. TPP-purified AAV particles infect at least as well as those prepared by standard methods.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.